Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma — Stella

Recruiting

Back to Melanoma Stage III trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Louisville, Louisville, Kentucky

Key details

Sponsor

Kelly McMasters

Enrollment target

~30 participants

Started

November 2020

Primary completion

July 2026

Age range

18 Years and older

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov